A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

April 4, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2025

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

GSK3915393

GSK3915393 will be administered.

DRUG

Placebo

Placebo will be administered.

Trial Locations (56)

1900

GSK Investigational Site, La Plata

10065

GSK Investigational Site, New York

19140

GSK Investigational Site, Philadelphia

20900

GSK Investigational Site, Monza MB

28006

GSK Investigational Site, Madrid

28007

GSK Investigational Site, Madrid

28223

GSK Investigational Site, Pozuelo de AlarcOn Madr

28401

GSK Investigational Site, Wilmington

30173

GSK Investigational Site, Hanover

31059

GSK Investigational Site, Toulouse

32224

GSK Investigational Site, Jacksonville

33011

GSK Investigational Site, Oviedo

33604

GSK Investigational Site, Pessac

33704

GSK Investigational Site, St. Petersburg

35000

GSK Investigational Site, Rennes

35128

GSK Investigational Site, Padua

37204

GSK Investigational Site, Nashville

38700

GSK Investigational Site, La Tronche

39011

GSK Investigational Site, Santander

41013

GSK Investigational Site, Seville

42283

GSK Investigational Site, Wuppertal

45293

GSK Investigational Site, Essen

55905

GSK Investigational Site, Rochester

56124

GSK Investigational Site, Pisa

69126

GSK Investigational Site, Heidelberg

75018

GSK Investigational Site, Paris

76000

GSK Investigational Site, Rouen

77429

GSK Investigational Site, Cypress

92663

GSK Investigational Site, Newport Beach

95123

GSK Investigational Site, Catania

48109-5360

GSK Investigational Site, Ann Arbor

C1426ABP

GSK Investigational Site, Buenos Aires

C1207AAP

GSK Investigational Site, Ciudad Autonoma de Bueno

B1602DQD

GSK Investigational Site, Florida

M5500CCG

GSK Investigational Site, Mendoza

S2000DBS

GSK Investigational Site, Rosario

V5Z 1M9

GSK Investigational Site, Vancouver

A1B 3V6

GSK Investigational Site, St. John's

L1S 2J5

GSK Investigational Site, Ajax

L8N 4A6

GSK Investigational Site, Hamilton

G8T 7A1

GSK Investigational Site, Trois-Rivières

Unknown

GSK Investigational Site, Napoli

GSK Investigational Site, Torrette AN

GSK Investigational Site, Barcelona

06132

GSK Investigational Site, Perugia

00168

GSK Investigational Site, Roma

07100

GSK Investigational Site, Sassari

5623 EJ

GSK Investigational Site, Eindhoven

3015 CE

GSK Investigational Site, Rotterdam

15-044

GSK Investigational Site, Bialystok

90-153

GSK Investigational Site, Lodz

60-569

GSK Investigational Site, Poznan

08907

GSK Investigational Site, Barcelona

EH16 4SA

GSK Investigational Site, Edinburgh

LS9 7TF

GSK Investigational Site, Leeds West Yorkshire

SW3 6HP

GSK Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY